🧾 Product Overview Table

🏷️ Parameter	🔍 Details
🧬 Active Ingredients	Dolutegravir 50mg + Lamivudine 300mg + Tenofovir Disoproxil 300mg
💊 Indication	HIV-1 infection treatment in adults
🇺🇸 US Equivalent	Dovato + Viread (component-wise equivalent)
🏭 Manufacturer	Emcure Pharmaceuticals Ltd. (Founded in 1981)
📦 Packaging	30 tablets in 1 bottle
💪 Strength	50mg/300mg/300mg
🚚 Delivery Time	6 to 15 days (Worldwide)

🧬 Introduction to Viropil
Viropil is a fixed-dose combination antiretroviral therapy (ART) containing Dolutegravir, Lamivudine, and Tenofovir Disoproxil. Manufactured by Emcure Pharmaceuticals Ltd, a leading Indian pharmaceutical firm, this medication is designed for once-daily administration to treat HIV-1 infection. The synergistic combination of these three agents helps prevent viral replication, lower viral load, and improve immune function. Viropil is widely used in both resource-limited settings and private sectors due to its proven efficacy and tolerability.

🎬 Educational Video

💉 Dosage & Indications

💊 Indication	💡 Standard Dosage	⏱️ Frequency	👥 Use Population
HIV-1 infection (Adults)	1 tablet (50/300/300mg) orally	Once daily	Adults & adolescents

Note: Should be taken with caution in patients with renal impairment.

⚠️ Side Effects, Warnings & Storage

❗ Common Side Effects: Nausea, headache, fatigue, insomnia, diarrhea
⚠️ Serious Side Effects: Lactic acidosis, liver toxicity, immune reconstitution syndrome
🧊 Storage: Store below 30°C in a dry place, away from sunlight
🔔 Precautions: Not recommended for patients with known hypersensitivity to any of the components

🌍 Global Availability

🌎 Country	📦 Shipping Availability	💵 Estimated Price (30 Tablets)	📜 Prescription Requirement
🇺🇸 USA	✅ Yes	$55–$80	Required
🇬🇧 UK	✅ Yes	£45–£70	Required
🇦🇺 Australia	✅ Yes	AUD 90–120	Required

🔗 Related Indian Alternatives (Different Molecules in Same Category)

💊 Brand Name	🏭 Manufacturer	🔗 Link
Telura	Hetero Healthcare Ltd.	Telura
Trioday	Cipla Limited	Trioday
Tenvir-EM	Cipla Limited	Tenvir-EM
Zidovudine + Lamivudine	Mylan Laboratories	Zidolam
Ricovir-L	Mylan Pharmaceuticals	Ricovir-L

📚 External Medical References

FDA – Antiretroviral Drugs
WHO – HIV Treatment Guidelines
NHS – HIV & AIDS Overview
Drugs.com – Dolutegravir/Lamivudine/Tenofovir

🩺 Expert Commentary
Dr. Anita George, Infectious Diseases Consultant:
“Viropil offers a complete daily regimen in one tablet. Its integrase inhibitor component (Dolutegravir) provides rapid viral suppression, while the nucleoside analogs contribute to backbone efficacy. It’s a WHO-recommended regimen with high success rates.”

🛡️ Final Medical Disclaimer
This article is for informational purposes only. Always consult your healthcare provider before beginning or changing any treatment.